PiaSky Prices, Coupons, Copay Cards & Patient Assistance
PiaSky (crovalimab) is a member of the selective immunosuppressants drug class and is commonly used for Paroxysmal Nocturnal Hemoglobinuria.
The cost for PiaSky (akkz 340 mg/2 mL) injectable solution is around $18,637 for a supply of 2 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
PiaSky prices
Injectable Solution
akkz 340 mg/2 mL
PiaSky injectable solution
from $18,637.07
for 2 milliliters
Quantity | Per unit | Price |
---|---|---|
2 milliliters | $9,318.54 | $18,637.07 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
PiaSky Coupons, Copay Cards and Rebates
PiaSky offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Patient Assistance & Copay Programs for PiaSky
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- PiaSky (crovalimab-akkz) Injection; IV or Subcutaneous
More information please phone: 866-316-7263 Visit Website
Provider: Genentech Patient Foundation
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- PiaSky (crovalimab-akkz) Injection; IV or Subcutaneous
More information please phone: 888-941-3331 or 866-422-2377 Visit Website
Provider: Genentech Access Solutions: PiaSky
Eligibility requirements:- Determined case by case
- Based on FPL
- FDA-approved diagnosis
- Must be residing in the US or US territory
- Eligibility determined on a case-by-case basis. Contact program for details. Co-payment assistance, and patient assistance programs are available for eligible patients.
- PiaSky (crovalimab-akkz) Injection; IV or Subcutaneous
More information please phone: 855-274-2759 or 866-422-2377 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about PiaSky (crovalimab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- En español